Skip to main content
OpenTrials

Clinical trial condition

Exophthalmos

Explore clinical trials studying Exophthalmos. Study availability and eligibility vary by location and protocol.

227 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Exophthalmos trial results

Recruiting

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

NCT07682896

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Site 112 Gilbert, Arizona, United States
  • Site 130 Phoenix, Arizona, United States
  • Site 121 La Mesa, California, United States
  • Site 103 Sacramento, California, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

NCT07722546

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • M3 Wake Research - Dallas Dallas, Texas, United States
  • Solace Clinical Research - Puerto Rico Bayamón, Puerto Rico
  • AME Clinical Research Los Angeles, California, United States
  • Asheville Clinical Research Asheville, North Carolina, United States
View Trial Details
Recruiting

A Clinical Study of Cizutamig in Thyroid Eye Disease

NCT07597200

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The Eighth Affiliated Hospital of Southern Medical University (Shunde District People's Hospital of Foshan City) Foshan, Guangdong, China
View all 14 locations
View Trial Details
Recruiting

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

NCT07404111

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Kriya Clinical Trial Site Livonia, Michigan, United States
  • Kriya Clinical Trial Site Las Vegas, Nevada, United States
  • Kriya Clinical Trial Site Erie, Pennsylvania, United States
  • Kriya Clinical Trial Site Auckland, New Zealand
View Trial Details
Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT07018323

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Site Number - 1015 Tucson, Arizona, United States
  • Site Number -1014 Concord, California, United States
  • Site Number - 1013 Aurora, Colorado, United States
  • Site Number - 1024 Doral, Florida, United States
View all 163 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

NCT06727604

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Site Number - 1032 Phoenix, Arizona, United States
  • Site Number - 1036 Phoenix, Arizona, United States
  • Site Number - 1061 Huntington Beach, California, United States
  • Site Number - 1001 Los Angeles, California, United States
View all 134 locations
View Trial Details
Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

NCT07305818

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +7 more
Locations
  • Site # 1101 Hollywood, Florida, United States
  • Site # 1112 Miami, Florida, United States
  • Site # 1109 Wesley Chapel, Florida, United States
  • Site # 1107 Boston, Massachusetts, United States
View all 15 locations
View Trial Details

Related conditions